The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Oncology Medication Market Research Report 2025
Synopsis
Cancer is the name given to a group of related diseases characterized by the uncontrolled and excessive growth of abnormal cells. More than 200 different types of cancer have been identified.
When these extra cells form a mass or a solid lump of tissue, it is called a tumor. Most cancers form tumors, but not all do. Tumors may be either benign or cancerous.
Benign tumors do not spread to other parts of the body and are rarely life-threatening. Many breast lumps, for example, are benign. Benign tumors are not cancer.
Malignant tumors crowd out healthy cells, interfere with body functions, and draw nutrients from body tissues. Malignant tumors can also spread to other parts of the body via the blood or lymphatic system, forming satellite tumors, called secondary cancers or metastases. Malignant tumors are cancer.
The global Oncology Medication market was valued at US$ 197440 million in 2023 and is anticipated to reach US$ 342140 million by 2030, witnessing a CAGR of 8.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Oncology Medication, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology Medication.
Report Scope
The Oncology Medication market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oncology Medication market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oncology Medication companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Celgene
Novartis
Bristol-Myers Squibb
Johnson & Johnson
Merck & Co.
AstraZeneca
Pfizer
Amgen
Takeda
Astellas
Ipsen
Sanofi
Bayer
Biogen Idec
Segment by Type
Chemotherapy Medication
Targeted Therapy Medication
Immunotherapy Medication
Hormonal Therapy Medication
Others
Segment by Application
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory or Lung Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oncology Medication companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Cancer is the name given to a group of related diseases characterized by the uncontrolled and excessive growth of abnormal cells. More than 200 different types of cancer have been identified.
When these extra cells form a mass or a solid lump of tissue, it is called a tumor. Most cancers form tumors, but not all do. Tumors may be either benign or cancerous.
Benign tumors do not spread to other parts of the body and are rarely life-threatening. Many breast lumps, for example, are benign. Benign tumors are not cancer.
Malignant tumors crowd out healthy cells, interfere with body functions, and draw nutrients from body tissues. Malignant tumors can also spread to other parts of the body via the blood or lymphatic system, forming satellite tumors, called secondary cancers or metastases. Malignant tumors are cancer.
The global Oncology Medication market was valued at US$ 197440 million in 2023 and is anticipated to reach US$ 342140 million by 2030, witnessing a CAGR of 8.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Oncology Medication, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology Medication.
Report Scope
The Oncology Medication market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oncology Medication market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oncology Medication companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Celgene
Novartis
Bristol-Myers Squibb
Johnson & Johnson
Merck & Co.
AstraZeneca
Pfizer
Amgen
Takeda
Astellas
Ipsen
Sanofi
Bayer
Biogen Idec
Segment by Type
Chemotherapy Medication
Targeted Therapy Medication
Immunotherapy Medication
Hormonal Therapy Medication
Others
Segment by Application
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory or Lung Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oncology Medication companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology Medication Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Chemotherapy Medication
1.2.3 Targeted Therapy Medication
1.2.4 Immunotherapy Medication
1.2.5 Hormonal Therapy Medication
1.2.6 Others
1.3 Market by Application
1.3.1 Global Oncology Medication Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Respiratory or Lung Cancer
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncology Medication Market Perspective (2019-2030)
2.2 Oncology Medication Growth Trends by Region
2.2.1 Global Oncology Medication Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Oncology Medication Historic Market Size by Region (2019-2024)
2.2.3 Oncology Medication Forecasted Market Size by Region (2025-2030)
2.3 Oncology Medication Market Dynamics
2.3.1 Oncology Medication Industry Trends
2.3.2 Oncology Medication Market Drivers
2.3.3 Oncology Medication Market Challenges
2.3.4 Oncology Medication Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncology Medication Players by Revenue
3.1.1 Global Top Oncology Medication Players by Revenue (2019-2024)
3.1.2 Global Oncology Medication Revenue Market Share by Players (2019-2024)
3.2 Global Oncology Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oncology Medication Revenue
3.4 Global Oncology Medication Market Concentration Ratio
3.4.1 Global Oncology Medication Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Medication Revenue in 2023
3.5 Oncology Medication Key Players Head office and Area Served
3.6 Key Players Oncology Medication Product Solution and Service
3.7 Date of Enter into Oncology Medication Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncology Medication Breakdown Data by Type
4.1 Global Oncology Medication Historic Market Size by Type (2019-2024)
4.2 Global Oncology Medication Forecasted Market Size by Type (2025-2030)
5 Oncology Medication Breakdown Data by Application
5.1 Global Oncology Medication Historic Market Size by Application (2019-2024)
5.2 Global Oncology Medication Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Oncology Medication Market Size (2019-2030)
6.2 North America Oncology Medication Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Oncology Medication Market Size by Country (2019-2024)
6.4 North America Oncology Medication Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oncology Medication Market Size (2019-2030)
7.2 Europe Oncology Medication Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Oncology Medication Market Size by Country (2019-2024)
7.4 Europe Oncology Medication Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oncology Medication Market Size (2019-2030)
8.2 Asia-Pacific Oncology Medication Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Oncology Medication Market Size by Region (2019-2024)
8.4 Asia-Pacific Oncology Medication Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oncology Medication Market Size (2019-2030)
9.2 Latin America Oncology Medication Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Oncology Medication Market Size by Country (2019-2024)
9.4 Latin America Oncology Medication Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncology Medication Market Size (2019-2030)
10.2 Middle East & Africa Oncology Medication Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Oncology Medication Market Size by Country (2019-2024)
10.4 Middle East & Africa Oncology Medication Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Oncology Medication Introduction
11.1.4 Roche Revenue in Oncology Medication Business (2019-2024)
11.1.5 Roche Recent Development
11.2 Celgene
11.2.1 Celgene Company Detail
11.2.2 Celgene Business Overview
11.2.3 Celgene Oncology Medication Introduction
11.2.4 Celgene Revenue in Oncology Medication Business (2019-2024)
11.2.5 Celgene Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Oncology Medication Introduction
11.3.4 Novartis Revenue in Oncology Medication Business (2019-2024)
11.3.5 Novartis Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Detail
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Oncology Medication Introduction
11.4.4 Bristol-Myers Squibb Revenue in Oncology Medication Business (2019-2024)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Detail
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Oncology Medication Introduction
11.5.4 Johnson & Johnson Revenue in Oncology Medication Business (2019-2024)
11.5.5 Johnson & Johnson Recent Development
11.6 Merck & Co.
11.6.1 Merck & Co. Company Detail
11.6.2 Merck & Co. Business Overview
11.6.3 Merck & Co. Oncology Medication Introduction
11.6.4 Merck & Co. Revenue in Oncology Medication Business (2019-2024)
11.6.5 Merck & Co. Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Detail
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Oncology Medication Introduction
11.7.4 AstraZeneca Revenue in Oncology Medication Business (2019-2024)
11.7.5 AstraZeneca Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Detail
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Oncology Medication Introduction
11.8.4 Pfizer Revenue in Oncology Medication Business (2019-2024)
11.8.5 Pfizer Recent Development
11.9 Amgen
11.9.1 Amgen Company Detail
11.9.2 Amgen Business Overview
11.9.3 Amgen Oncology Medication Introduction
11.9.4 Amgen Revenue in Oncology Medication Business (2019-2024)
11.9.5 Amgen Recent Development
11.10 Takeda
11.10.1 Takeda Company Detail
11.10.2 Takeda Business Overview
11.10.3 Takeda Oncology Medication Introduction
11.10.4 Takeda Revenue in Oncology Medication Business (2019-2024)
11.10.5 Takeda Recent Development
11.11 Astellas
11.11.1 Astellas Company Detail
11.11.2 Astellas Business Overview
11.11.3 Astellas Oncology Medication Introduction
11.11.4 Astellas Revenue in Oncology Medication Business (2019-2024)
11.11.5 Astellas Recent Development
11.12 Ipsen
11.12.1 Ipsen Company Detail
11.12.2 Ipsen Business Overview
11.12.3 Ipsen Oncology Medication Introduction
11.12.4 Ipsen Revenue in Oncology Medication Business (2019-2024)
11.12.5 Ipsen Recent Development
11.13 Sanofi
11.13.1 Sanofi Company Detail
11.13.2 Sanofi Business Overview
11.13.3 Sanofi Oncology Medication Introduction
11.13.4 Sanofi Revenue in Oncology Medication Business (2019-2024)
11.13.5 Sanofi Recent Development
11.14 Bayer
11.14.1 Bayer Company Detail
11.14.2 Bayer Business Overview
11.14.3 Bayer Oncology Medication Introduction
11.14.4 Bayer Revenue in Oncology Medication Business (2019-2024)
11.14.5 Bayer Recent Development
11.15 Biogen Idec
11.15.1 Biogen Idec Company Detail
11.15.2 Biogen Idec Business Overview
11.15.3 Biogen Idec Oncology Medication Introduction
11.15.4 Biogen Idec Revenue in Oncology Medication Business (2019-2024)
11.15.5 Biogen Idec Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Oncology Medication Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Chemotherapy Medication
Table 3. Key Players of Targeted Therapy Medication
Table 4. Key Players of Immunotherapy Medication
Table 5. Key Players of Hormonal Therapy Medication
Table 6. Key Players of Others
Table 7. Global Oncology Medication Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Oncology Medication Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Oncology Medication Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Oncology Medication Market Share by Region (2019-2024)
Table 11. Global Oncology Medication Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Oncology Medication Market Share by Region (2025-2030)
Table 13. Oncology Medication Market Trends
Table 14. Oncology Medication Market Drivers
Table 15. Oncology Medication Market Challenges
Table 16. Oncology Medication Market Restraints
Table 17. Global Oncology Medication Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Oncology Medication Market Share by Players (2019-2024)
Table 19. Global Top Oncology Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Medication as of 2023)
Table 20. Ranking of Global Top Oncology Medication Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Oncology Medication Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Oncology Medication Product Solution and Service
Table 24. Date of Enter into Oncology Medication Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Oncology Medication Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Oncology Medication Revenue Market Share by Type (2019-2024)
Table 28. Global Oncology Medication Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Oncology Medication Revenue Market Share by Type (2025-2030)
Table 30. Global Oncology Medication Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Oncology Medication Revenue Market Share by Application (2019-2024)
Table 32. Global Oncology Medication Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Oncology Medication Revenue Market Share by Application (2025-2030)
Table 34. North America Oncology Medication Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Oncology Medication Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Oncology Medication Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Oncology Medication Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Oncology Medication Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Oncology Medication Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Oncology Medication Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Oncology Medication Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Oncology Medication Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Oncology Medication Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Oncology Medication Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Oncology Medication Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Oncology Medication Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Oncology Medication Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Oncology Medication Market Size by Country (2025-2030) & (US$ Million)
Table 49. Roche Company Detail
Table 50. Roche Business Overview
Table 51. Roche Oncology Medication Product
Table 52. Roche Revenue in Oncology Medication Business (2019-2024) & (US$ Million)
Table 53. Roche Recent Development
Table 54. Celgene Company Detail
Table 55. Celgene Business Overview
Table 56. Celgene Oncology Medication Product
Table 57. Celgene Revenue in Oncology Medication Business (2019-2024) & (US$ Million)
Table 58. Celgene Recent Development
Table 59. Novartis Company Detail
Table 60. Novartis Business Overview
Table 61. Novartis Oncology Medication Product
Table 62. Novartis Revenue in Oncology Medication Business (2019-2024) & (US$ Million)
Table 63. Novartis Recent Development
Table 64. Bristol-Myers Squibb Company Detail
Table 65. Bristol-Myers Squibb Business Overview
Table 66. Bristol-Myers Squibb Oncology Medication Product
Table 67. Bristol-Myers Squibb Revenue in Oncology Medication Business (2019-2024) & (US$ Million)
Table 68. Bristol-Myers Squibb Recent Development
Table 69. Johnson & Johnson Company Detail
Table 70. Johnson & Johnson Business Overview
Table 71. Johnson & Johnson Oncology Medication Product
Table 72. Johnson & Johnson Revenue in Oncology Medication Business (2019-2024) & (US$ Million)
Table 73. Johnson & Johnson Recent Development
Table 74. Merck & Co. Company Detail
Table 75. Merck & Co. Business Overview
Table 76. Merck & Co. Oncology Medication Product
Table 77. Merck & Co. Revenue in Oncology Medication Business (2019-2024) & (US$ Million)
Table 78. Merck & Co. Recent Development
Table 79. AstraZeneca Company Detail
Table 80. AstraZeneca Business Overview
Table 81. AstraZeneca Oncology Medication Product
Table 82. AstraZeneca Revenue in Oncology Medication Business (2019-2024) & (US$ Million)
Table 83. AstraZeneca Recent Development
Table 84. Pfizer Company Detail
Table 85. Pfizer Business Overview
Table 86. Pfizer Oncology Medication Product
Table 87. Pfizer Revenue in Oncology Medication Business (2019-2024) & (US$ Million)
Table 88. Pfizer Recent Development
Table 89. Amgen Company Detail
Table 90. Amgen Business Overview
Table 91. Amgen Oncology Medication Product
Table 92. Amgen Revenue in Oncology Medication Business (2019-2024) & (US$ Million)
Table 93. Amgen Recent Development
Table 94. Takeda Company Detail
Table 95. Takeda Business Overview
Table 96. Takeda Oncology Medication Product
Table 97. Takeda Revenue in Oncology Medication Business (2019-2024) & (US$ Million)
Table 98. Takeda Recent Development
Table 99. Astellas Company Detail
Table 100. Astellas Business Overview
Table 101. Astellas Oncology Medication Product
Table 102. Astellas Revenue in Oncology Medication Business (2019-2024) & (US$ Million)
Table 103. Astellas Recent Development
Table 104. Ipsen Company Detail
Table 105. Ipsen Business Overview
Table 106. Ipsen Oncology Medication Product
Table 107. Ipsen Revenue in Oncology Medication Business (2019-2024) & (US$ Million)
Table 108. Ipsen Recent Development
Table 109. Sanofi Company Detail
Table 110. Sanofi Business Overview
Table 111. Sanofi Oncology Medication Product
Table 112. Sanofi Revenue in Oncology Medication Business (2019-2024) & (US$ Million)
Table 113. Sanofi Recent Development
Table 114. Bayer Company Detail
Table 115. Bayer Business Overview
Table 116. Bayer Oncology Medication Product
Table 117. Bayer Revenue in Oncology Medication Business (2019-2024) & (US$ Million)
Table 118. Bayer Recent Development
Table 119. Biogen Idec Company Detail
Table 120. Biogen Idec Business Overview
Table 121. Biogen Idec Oncology Medication Product
Table 122. Biogen Idec Revenue in Oncology Medication Business (2019-2024) & (US$ Million)
Table 123. Biogen Idec Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oncology Medication Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Oncology Medication Market Share by Type: 2023 VS 2030
Figure 3. Chemotherapy Medication Features
Figure 4. Targeted Therapy Medication Features
Figure 5. Immunotherapy Medication Features
Figure 6. Hormonal Therapy Medication Features
Figure 7. Others Features
Figure 8. Global Oncology Medication Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Oncology Medication Market Share by Application: 2023 VS 2030
Figure 10. Blood Cancer Case Studies
Figure 11. Breast Cancer Case Studies
Figure 12. Gastrointestinal Cancer Case Studies
Figure 13. Prostate Cancer Case Studies
Figure 14. Respiratory or Lung Cancer Case Studies
Figure 15. Others Case Studies
Figure 16. Oncology Medication Report Years Considered
Figure 17. Global Oncology Medication Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 18. Global Oncology Medication Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global Oncology Medication Market Share by Region: 2023 VS 2030
Figure 20. Global Oncology Medication Market Share by Players in 2023
Figure 21. Global Top Oncology Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Medication as of 2023)
Figure 22. The Top 10 and 5 Players Market Share by Oncology Medication Revenue in 2023
Figure 23. North America Oncology Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. North America Oncology Medication Market Share by Country (2019-2030)
Figure 25. United States Oncology Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Canada Oncology Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Oncology Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Europe Oncology Medication Market Share by Country (2019-2030)
Figure 29. Germany Oncology Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. France Oncology Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. U.K. Oncology Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Italy Oncology Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Russia Oncology Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Nordic Countries Oncology Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Oncology Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Asia-Pacific Oncology Medication Market Share by Region (2019-2030)
Figure 37. China Oncology Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Japan Oncology Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. South Korea Oncology Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Oncology Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. India Oncology Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Australia Oncology Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Oncology Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Latin America Oncology Medication Market Share by Country (2019-2030)
Figure 45. Mexico Oncology Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Brazil Oncology Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Oncology Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Oncology Medication Market Share by Country (2019-2030)
Figure 49. Turkey Oncology Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Oncology Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Roche Revenue Growth Rate in Oncology Medication Business (2019-2024)
Figure 52. Celgene Revenue Growth Rate in Oncology Medication Business (2019-2024)
Figure 53. Novartis Revenue Growth Rate in Oncology Medication Business (2019-2024)
Figure 54. Bristol-Myers Squibb Revenue Growth Rate in Oncology Medication Business (2019-2024)
Figure 55. Johnson & Johnson Revenue Growth Rate in Oncology Medication Business (2019-2024)
Figure 56. Merck & Co. Revenue Growth Rate in Oncology Medication Business (2019-2024)
Figure 57. AstraZeneca Revenue Growth Rate in Oncology Medication Business (2019-2024)
Figure 58. Pfizer Revenue Growth Rate in Oncology Medication Business (2019-2024)
Figure 59. Amgen Revenue Growth Rate in Oncology Medication Business (2019-2024)
Figure 60. Takeda Revenue Growth Rate in Oncology Medication Business (2019-2024)
Figure 61. Astellas Revenue Growth Rate in Oncology Medication Business (2019-2024)
Figure 62. Ipsen Revenue Growth Rate in Oncology Medication Business (2019-2024)
Figure 63. Sanofi Revenue Growth Rate in Oncology Medication Business (2019-2024)
Figure 64. Bayer Revenue Growth Rate in Oncology Medication Business (2019-2024)
Figure 65. Biogen Idec Revenue Growth Rate in Oncology Medication Business (2019-2024)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
